-
1
The long-term clinical efficacy and safety of lenvatinib plus pembrolizumab in endometrial cancer: data from routine clinical practice in Russia
Published 2024-11-01Subjects: “…immunotargeted therapy…”
Get full text
Article -
2
-
3
Combination of pembrolizumab and lenvatinib in second-line therapy for MSS/pMMR advanced endometrial cancer: literature review and a case report
Published 2024-01-01Subjects: Get full text
Article -
4
Efficient sequence of therapy for advanced and metastatic endometrial cancer
Published 2022-09-01Subjects: Get full text
Article -
5
Clinical and morphological features in patients with advanced endometrial cancer treated with immunotargeting therapy
Published 2023-08-01Subjects: Get full text
Article